TriWise Capital
Asia, Guangdong, China, Shenzhen'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
TriWise Capital is an investment firm that focuses on venture capital and M&A business.
Investor Profile
TriWise Capital has backed more than 9 startups, with 4 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Seed, Series D rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 3 rounds in the past year.
Stage Focus
- Series C (33%)
- Seed (22%)
- Series D (22%)
- Series A (11%)
- Angel (11%)
Country Focus
- China (67%)
- United States (11%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Biopharma
- Pharmaceutical
- Oncology
- Therapeutics
- Life Science
- Pet
- Veterinary
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
